Medical Devices Late Stage Investors & VC Firms
489 firms in this list, with a median first check of $1.1M. 105 of them lead rounds. Generated from verified public data and updated continuously.
Quad Ventures
SeoulPre-Seed–Late Stage
4 people
Sherpa Healthcare Partners
Grand CaymanSeed–Late Stage
3 people
Jumpstart Health Investors
NashvillePre-Seed–Late Stage
5 people
WONIK Investment Partners
SeoulSeries A–Late Stage
11 people
Klein & Partners AG
ZugGrowth–Late Stage$550K – $5.5M
2 people
MCI Capital S.A.
WarsawGrowth–Late Stage$27M – $108M
2 people
HealthCare Ventures, LLC
CambridgeSeries A–Late Stage$1M – $20M
1 person
Exit 156 Capital
CollegevilleGrowth–Late Stage
3 people
Pamica NV
AntwerpSeed–Late Stage
1 person
Heron Capital
IndianapolisSeries A–Late Stage$10M
3 people
Shanghai Creation Investment
ShanghaiLate Stage
Trinity Innovation Bioventure Singapore
SingaporeSeed–Late Stage
3 people
Majuven
SingaporeSeed–Late Stage
4 people
South China Venture Capital
ShenzhenSeed–Late Stage
4 people
TTP Ventures
CambridgeSeed–Late Stage
Fluke Venture Partners
KirklandSeed–Late Stage$1M – $4M
1 person
Aravis Ventures
ZurichSeed–Late Stage
4 people
Abbhi Capital
MiamiPre-Seed–Late Stage
Gurnet Point Capital
Pre-Seed–Late Stage
3 people
Invest Northern Ireland
BelfastSeed–Late Stage
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
Rivus Capital
MunichSeed–Late Stage$5M – $20M
Sangel Capital
ShenzhenSeed–Late Stage
Hotung Investment Holdings Ltd.
SingaporeSeries A–Late Stage$300K – $1.5M
Related lists
Late Stage Investors & VC Firms (2974)Late Stage Investors & VC Firms in North America (1695)Late Stage Investors & VC Firms in United States (1516)Medical Devices Investors & VC Firms (1452)Medical Devices Seed Investors & VC Firms (1202)Medical Devices Series A Investors & VC Firms (1187)Late Stage Investors & VC Firms in Europe (965)Medical Devices Investors & VC Firms in North America (948)Healthtech Late Stage Investors & VC Firms (925)Late Stage Investors & VC Firms in Global (904)
Data sourced from public filings and firms' own websites — see our methodology.




















